Sclerosing cholangitis as a side effect caused by the drug:
High-Yield Explanation
Sclerosing cholangitis develops after intrahepatic infusion of the chemotherapeutic agent floxuridine for hepatic metastases from a primary colonic carcinoma. Reference: Harrisons Principles of Internal Medicine, 18th Edition, Page 2560